Fetal Rhesus Factor D (RhD) genotyping is typically performed through non-invasive prenatal testing (NIPT) and is important in identifying RhD incompatibility between mother and child.
The FetoGnost® Kit RHD from Ingenetix allows rapid, sensitive, and non-invasive fetal RhD genotyping of samples purified from maternal plasma of RhD-negative pregnant women, based on real-time PCR technology. In this app note, you will explore the compatibility of the FetoGnost® Kit RHD with extracted cffDNA obtained with the chemagic™ 360 instrument using RhD-positive or -negative plasma from blood donors.
Find out more on Revvity's website here
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
